Zentiva SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zentiva SA with three other
pharmaceutical manufacturers in Europe:
Cathay International Holdings Ltd
of the United Kingdom
sales of £88.59 million [US$124.24 million]
(361.65 million Polish New Zlotys [US$106.34 million]
of which 59%
was Insulin (Bioton SA)), and
Solon Eiendom ASA
based in Norway
(883.04 million Norwegian Kroner [US$112.60 million]
During the year ended December of 2017, sales at
Zentiva SA were 458.60 million Romanian Leu (US$120.75 million).
increase of 9.2%
versus 2016, when the company's sales were 420.00 million Romanian Leu.
This was the fifth consecutive year of sales increases at Zentiva SA
(and since 2012, sales have increased a total of 76%).